Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
The Effect of Topical Cysteamine Drops on Reducing Crystal Formation Within the Cornea of Patients Affected by Nephropathic Cystinosis
View through CrossRef
ABSTRACT
We studied the usefulness of topical cysteamine ophthalmic drops in reducing crystal formation within the corneas of patients affected by nephropathic cystinosis. A dosage of 0.3% cysteamine given four times daily was chosen as a more manageable method than a previously reported protocol of hourly administration of 0.11% drops. No reduction in crystal formation was observed in our patients; they were followed for seven months.
Title: The Effect of Topical Cysteamine Drops on Reducing Crystal Formation Within the Cornea of Patients Affected by Nephropathic Cystinosis
Description:
ABSTRACT
We studied the usefulness of topical cysteamine ophthalmic drops in reducing crystal formation within the corneas of patients affected by nephropathic cystinosis.
A dosage of 0.
3% cysteamine given four times daily was chosen as a more manageable method than a previously reported protocol of hourly administration of 0.
11% drops.
No reduction in crystal formation was observed in our patients; they were followed for seven months.
Related Results
A Personal History of Cystinosis by Dr. Jerry Schneider
A Personal History of Cystinosis by Dr. Jerry Schneider
Cystinosis is a rare lysosomal storage disease that is tightly linked with the name of the American physician and scientist Dr. Jerry Schneider. Dr. Schneider (1937–2021) received ...
Analysis of tear film in cystinosis patients treated with topical viscous cysteamine hydrochloride (Cystadrops®)
Analysis of tear film in cystinosis patients treated with topical viscous cysteamine hydrochloride (Cystadrops®)
Purpose The aim of this study was to evaluate in vivo the tear film in infantile nephropathic cystinosis patients with corneal crystals treated with topical viscous cysteamine hydr...
#4432 ECYSCO: A EUROPEAN COHORT DEDICATED TO CYSTINOSIS
#4432 ECYSCO: A EUROPEAN COHORT DEDICATED TO CYSTINOSIS
Abstract
Background and Aims
Cystinosis is a rare multisystem lysosomal storage disease due to variants in the CTNS gene, coding...
Worldwide disparities in access to treatment and investigations for nephropathic cystinosis: a 2023 perspective
Worldwide disparities in access to treatment and investigations for nephropathic cystinosis: a 2023 perspective
Abstract
Background
Nephropathic cystinosis (NC) is a rare lysosomal disease, leading to early kidney failure and extra-renal comorbidities. Its pro...
Infantile Nephropathic Cystinosis in Sulaimani Pediatric Teaching Hospital: A Retrospective Cohort Study
Infantile Nephropathic Cystinosis in Sulaimani Pediatric Teaching Hospital: A Retrospective Cohort Study
Cystinosis is a rare metabolic autosomal recessive disorder which characterized by intralysosomal accumulation of cystine. There are three forms; infantile nephropathic is the comm...
#2245 ECYSCO, a European cystinosis cohort
#2245 ECYSCO, a European cystinosis cohort
Abstract
Background and Aims
Cystinosis is a rare multisystem lysosomal storage disease due to variants in the CTNS gene, coding...
Literatur Review: Cysteamine Terapi Terkini Hiperpigmentasi yang Menjanjikan
Literatur Review: Cysteamine Terapi Terkini Hiperpigmentasi yang Menjanjikan
Cysteamine, an aminothiol compound naturally produced in human cells, is emerging as an effective depigmenting agent to treat hyperpigmentation conditions such as melasma and lenti...
ESTUDO COMPARATIVO DA EFICÁCIA DE TRATAMENTOS PARA O MELASMA: KLIGMAN E CYSTEAMINE
ESTUDO COMPARATIVO DA EFICÁCIA DE TRATAMENTOS PARA O MELASMA: KLIGMAN E CYSTEAMINE
Objetivo: Analisar a eficácia de Kligman em comparação com Cysteamine para o tratamento de melasma em pacientes de 27 a 44 anos sem tratamento atualmente. Métodos: Trata-se de um e...